• Colistimethate (As Sodium)
  • No Brand Name
  • Solution and Powder for Injection
  • 1,000,000 IU
  • Vial
  • -
-
•    Susceptible Infections

Mechanism of Action
Structurally similar to polymyxin B, colistimethate hydrolyzed to colistin in vitro or in vivo
Cationic detergent that damages bacterial cytoplasmic membrane, causing cell death
Pharmacokinetics
-
Contraindications
•    Hypersensitivity
Adverse Reactions
Dizziness, Paresthesia, Tingling of extremities and tongue
Major Drug Interactions
-
Warnings
•    Not indicated for infections by Proteus or Neisseria
Recommendations for Patient
-
Pregnancy Considerations
Category: C
Breastfeeding Considerations
Unknown, Use caution

 

Pregnancy Categories
A: Generally acceptable. Controlled studies in pregnant women show no evidence of fetal risk.
B: May be acceptable. Either animal studies show no risk but human studies not available or animal studies showed minor risks and human studies done and showed no risk.
C: Use with caution if benefits outweigh risks. Animal studies show risk and human studies not available or neither animal nor human studies done.
D: Use in LIFE-THREATENING emergencies when no safer drug available. Positive evidence of human fetal risk.
X: Do not use in pregnancy. Risks involved outweigh potential benefits. Safer alternatives exist.
NA: Information not available.


Send to other people

http://en.dppharma.com/products/detail/colistimethate1-iu